EMA revised guideline on quality of biosimilar medicines open for comments
05:12 EDT 8 Jun 2012 | GaBI online
EMA announced on 31 May 2012 that it had released a revised guideline for public consultation describing how pharmaceutical companies should address the quality aspects of biosimilar medicines.
Original Article: EMA revised guideline on quality of biosimilar medicines open for comments
More From BioPortfolio on "EMA revised guideline on quality of biosimilar medicines open for comments"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
